Posted in M&A / Deals Tortugas debuts with $106M and brain drugs from Hansoh, Eisai April 21, 2026 BioPharma Dive Led by former Sage Therapeutics executives Jeff Jonas and Al Robichaud, the company is starting out with a portfolio of neurological medicines in clinical testing. M&A / DealsNeuroscienceRead full story